The webinar provided a comprehensive overview of the latest developments in clinical trials, with each company sharing updates and preliminary insights from their ongoing or completed studies in HD treatment. These presentations underscored the diversity of approaches and the progress being made across therapeutic areas.
The session concluded with a Q&A, where attendees had the opportunity to pose questions directly to the panel, facilitating a valuable discussion on the current state and future potential of HD research.
This webinar is part of EHA’s ongoing commitment to keeping the HD community informed about cutting-edge research efforts aimed at improving the lives of those affected by Huntington’s disease.
– Article written by Beatriz Campaniço
MENU
MENU
Save the date and join us at the EHA Conference!
We’re bringing together families, professionals, and supporters to strengthen the HD community đź’™ You can also make a difference by joining our Teaming initiative, donating just €1 per month to support families affected by Huntington’s disease. Together, we get stronger!
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLearn more